10/02/2025 | Press release | Distributed by Public on 10/02/2025 07:51
Supplement dated October 2, 2025
To the Prospectuses Dated
May 1, 2019
PARTNERS VARIABLE ANNUITY SERIES®
Issued by
TRANSAMERICA LIFE INSURANCE COMPANY
Separate Account VA B
And
TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY
Separate Account VA BNY
Effective on or about the close of business on December 5, 2025 (the "Liquidation Date"), due to the liquidation of the underlying portfolio listed below (the "Portfolio"), the subaccount (the "Subaccount") will be liquidated.
SUBACCOUNT NAME | PORTFOLIO NAME | SUBADVISOR |
Voya Large Cap Value Portfolio | Voya Large Cap Value Portfolio | Voya Investments, LLC |
If you have contract value allocated to the Subaccount on the Liquidation Date, shares of the Portfolio held for you in the Subaccount will be exchanged for shares of the Transamerica BlackRock Government Money Market VP (the "Money Market Portfolio"), of equal value on the Liquidation Date, and held in the Transamerica BlackRock Government Money Market VP subaccount (the "Money Market Subaccount").
As of the start of business on the Liquidation Date, you will no longer be able to use automated transfer features such as Rebalancing Program or Dollar Cost Averaging with the Subaccount for the Portfolio. If you are using an automated transfer feature such as Rebalancing Program or Dollar Cost Averaging with the Subaccount for the Portfolio, you should contact us immediately to make alternate arrangements. If you do not make alternate arrangements any subsequent allocations to the Subaccount for the Portfolio will be directed to the Money Market Subaccount.
This Supplement updates certain information in the above referenced prospectus (the ''Prospectus''). Except as indicated in this Supplement, all other information included in the Prospectus remains unchanged. We will send you another copy of the current Prospectus or any supplement without charge upon request. Please contact our Administrative Office referenced in the Prospectus.
This Supplement must be accompanied or preceded by the current Prospectus.
Please read this Supplement carefully and retain it for future reference.